Activities

• 

  Mary Grace N. Tamio   

  on April 03 2021 at 08:01 PM Edited public

  Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer
  
  #fistula #organperforation #lenvatinib #thyroidcancer #karger
  
  For more information | ⬇️
  https://social.cn1699.cn/livenewss/news/56891/Prevalence-and-Risk-Factors-of-Developing-Fistula-or-Organ-Perforation-in-Patients-Treated-with-Lenvatinib-for-Radioiodine-Refractory-Thyroid-Cancer

  

  Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer | CN1699 Social

  The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share